Endothelial glycocalyx · blood sugar

The Endothelial Glycocalyx: The Lining Sugar Strips First

The endothelial glycocalyx is the soft gel lining the inside of your arteries that keeps blood cells from sticking, holds fluid inside the vessel and tells the artery when to widen.

The inside of an artery is coated in a soft gel that decides how blood flows and what leaks. High blood sugar strips it in hours, long before a scan finds anything.

Every artery you own is coated on the inside with a soft, sugar-based gel a fraction of a hair wide. The endothelial glycocalyx is that coating, and it does more work than its size suggests: it keeps blood cells from sticking, holds fluid and protein inside the vessel, and translates the push of flowing blood into the signal that tells an artery to widen. Nothing on a standard panel reports it, though vessel stiffness and dilation testing can measure the job it does. The reason it belongs in a conversation about blood sugar is timing. This layer is not lost over decades of plaque buildup. It thins in hours.

A layer built to be sacrificed

The glycocalyx is a wearable part. It is constantly built up and constantly shed, and that turnover is the point: a lining that can be stripped and replaced can absorb insult. Shedding is enzymatic, and the enzymes that cut it loose are switched on by oxidative stress and inflammatory signaling. When tearing down outruns building back, the cells underneath are left bare against flowing blood, and the layer that carried the widen-the-vessel signal is gone. Current vessel biology treats that imbalance in turnover as the root of what clinics call endothelial dysfunction. What follows is the ordinary sequence: fluid leaks where it should not, white cells and platelets find the wall sticky, and small arteries lose the ability to open on demand. Dr. Padda spent years telling people whose sugars sat a little above the line that this was not something to worry about yet. This is part of the physiology that changed his mind.

What one high blood sugar does, measured

The cleanest human demonstration is an old one. Investigators measured the whole-body volume of this layer in 10 healthy men by comparing how two tracers spread through the circulation, one able to enter the gel and one not. At rest the measurement repeated at about 1.7 liters. During a few hours of controlled high blood sugar, with insulin held steady so insulin itself was not the variable, it fell to roughly 0.8 liters. Hyaluronan, one of the layer’s own building blocks, rose in the blood as it came off the wall. Clotting markers rose with it, and vessel function worsened in the same session. An infusion that concentrated the blood without adding glucose did nothing, so this was the sugar, not the osmotic load.

Read that against a glucose meter. A number that peaks after a meal and settles by morning is usually treated as a non-event because the fasting value looks fine. The lining does not average your day, and the silent inflammation sugar sets off runs on the same clock. The gums register the same post-meal injury in tissue you can see, discussed in what bleeding gums can say about sugar.

From a spike to a pattern

Measured in people who live with high blood sugar, the layer falls in steps. In adults with type 1 diabetes, glycocalyx volume ran about 1.5 liters in controls, lower in patients whose kidneys were not yet leaking protein, and about 0.2 liters in those with protein in the urine. The groups were tiny, 7 people each, so the direction matters more than the decimals: the layer is thinnest in the people whose smallest vessels have already declared themselves.

In type 2 diabetes, the layer measured under the tongue and in the retina was thinner than in controls, and albumin escaped the capillaries faster. A newer sublingual camera found the same thinning in 65 adults with type 2 diabetes compared with 42 matched controls, alongside stiffer large arteries and changes in the retinal microcirculation. None of these measurements is a Measura test, and none is a routine clinical test anywhere; they are research tools, which is why the practical question becomes what a person can measure instead.

Where your fat sits shows up in the lining

The most useful recent finding has nothing to do with glucose numbers. Researchers measured a blood marker of shed glycocalyx in 219 adults without diabetes and 203 adults with type 2 diabetes, and compared it against imaging and body composition. Median levels ran 16.0 nanograms per milliliter in the group without diabetes and 26.5 in the group with it. Within each group the marker rose with the amount of fat packed inside the abdomen. Neither body mass index nor the fat under the skin tracked it at all. The difference between those compartments is laid out in visceral versus subcutaneous fat.

That is the second biological driver, and it is not sugar. Visceral fat is an endocrine organ, and the metaflammation it pumps into the circulation is the switch that turns shedding enzymes on. Insulin resistance sits underneath both: it fills that depot and keeps post-meal glucose elevated. The third driver is not biology at all. Refined starch and industrial seed oils are engineered to be the most available calories on every shelf, so the post-meal spike is a feature of the food supply rather than a personal failure. A layer stripped several times a day, every day, never gets a quiet stretch to rebuild.

What a standard visit sees, and what it skips

A routine visit takes a blood pressure at the arm and orders a cholesterol panel and perhaps an A1C. All three are worth having, and all three read late. An A1C is a three-month average that hides the spikes doing the damage, while a fasting insulin result reads the compensation years earlier. A cholesterol panel counts particles; it says nothing about whether your vessels can open. Blood pressure at the arm is a downstream consequence of stiffness that has already set in. The checkup measures the smoke after the fire has spread, then calls a normal reading reassurance.

What Measura can measure in the same person

Measura [Cardiometabolic and Autonomic Health Analysis] is a testing service. It measures and sends findings to your physician; it does not treat, and it cannot image your glycocalyx. What it can do is measure the functions that layer is responsible for, in you, today.

Arterial stiffness and endothelial function testing asks how stiff your larger arteries are and how well the lining lets them widen, the job the glycocalyx starts.
Photoplethysmography uses light at the skin to read the pulse in the smallest vessels, where leaking and sticking happen first.
Pulse volume recording traces the pulse waveform along the arms and legs to show how blood is moving through those arteries.
Laboratory panels cover the drivers: fasting insulin reported beside glucose, inflammatory markers, and lipid particle detail rather than total cholesterol alone.

A single reading is a starting point, not a verdict. What endothelial dysfunction is and how it is tested covers the vessel-function side once results are in hand, and why a normal ankle-brachial index can be misleading explains how a reassuring circulation number can still miss small-vessel trouble.

What appears to move it

Human intervention evidence is thin, because the trials that would settle it isolate one disease and exclude the comorbid metabolic patient described here. What exists points one way. In fifty healthy young adults doing sprint-interval training, a thicker measured glycocalyx went with greater exercise capacity both before and after the program. In adults with type 2 diabetes given a glycocalyx building block by mouth for 2 months, the measured layer thickened and albumin leak trended back toward normal. In 28 adults with type 2 diabetes and 33 without who had bariatric surgery, shedding markers improved over two years, and what best predicted the improvement was loss of body weight and fat mass and a gain in insulin sensitivity.

Put plainly, the layer responds to the terrain, not to a single number. Lowering the height of your after-meal glucose, shrinking the visceral depot, and moving hard enough to make your circulation work are the levers with mechanism behind them. Ask your physician for fasting insulin next to glucose, ask what your after-meal numbers look like rather than the average, and ask whether a vessel-function measurement belongs beside the arm cuff. Finding cardiovascular risk early describes how that testing fits a checkup. Medication decisions stay with your physician, never with a single result. Unmeasured is unmanaged, and this is a layer nobody has ever measured in you. When glucose delivery to the brain falters, a second fuel can still get in, the subject of the fuel an insulin-resistant brain can still use.

Frequently asked questions

Can my glycocalyx be tested at my appointment?

Not at Measura, and not in routine care anywhere. The research above used tracer dilution, a sublingual microscope camera or retinal angiography, all research methods. What can be measured in the same person is the function that layer governs: arterial stiffness and dilation, small-vessel pulse, and the metabolic blood work behind both. What a test result can and cannot tell you sets the expectation.

Does a normal A1C mean my vessel lining is safe?

An A1C is an average across about three months, and the damage documented here followed hours of raised glucose. A person with an unremarkable average can still spike hard after meals, and the layer responds to the peak, not the mean. Insulin usually rises years before glucose does, which is why it belongs on the panel. High insulin with normal blood sugar explains that gap.

Why does my waist matter more than my weight here?

Because the blood marker of a shed lining tracked the fat packed inside the abdomen and tracked neither body mass index nor the fat under the skin. That depot sends inflammatory signals into the circulation that switch on the enzymes stripping the layer, so two people at the same weight can be in different vascular situations. How to measure visceral fat covers what separates the two.

If I cannot measure the layer, what should I track?

Track what drives it and what it serves: fasting insulin beside glucose, a marker of inflammation, where your fat sits, and a vessel-function measurement you can repeat under the same conditions. One set of numbers now becomes the baseline that tells you, a year from now, whether anything you changed reached your arteries. What insulin resistance looks like before diabetes describes the earliest stage.

Measure what the lining protects

Request Measura testing for vessel function, small-vessel pulse and metabolic blood work, with results sent to your physician. Bring the report to the clinician who manages your blood sugar.

Send a message

4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

References

Nieuwdorp, M., van Haeften, T. W., Gouverneur, M. C., Mooij, H. L., van Lieshout, M. H., Levi, M., Meijers, J. C., Holleman, F., Hoekstra, J. B., Vink, H., Kastelein, J. J., & Stroes, E. S. (2006). Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes, 55(2), 480-486. https://doi.org/10.2337/diabetes.55.02.06.db05-1103
Nieuwdorp, M., Mooij, H. L., Kroon, J., Atasever, B., Spaan, J. A., Ince, C., Holleman, F., Diamant, M., Heine, R. J., Hoekstra, J. B., Kastelein, J. J., Stroes, E. S., & Vink, H. (2006). Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes, 55(4), 1127-1132. https://doi.org/10.2337/diabetes.55.04.06.db05-1619
Broekhuizen, L. N., Lemkes, B. A., Mooij, H. L., Meuwese, M. C., Verberne, H., Holleman, F., Schlingemann, R. O., Nieuwdorp, M., Stroes, E. S., & Vink, H. (2010). Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia, 53(12), 2646-2655. https://doi.org/10.1007/s00125-010-1910-x
Miyamoto, S., Kakutani, Y., Morioka, T., Yamazaki, Y., Ochi, A., Fukumoto, S., Shoji, T., & Emoto, M. (2025). Association of Visceral Fat Accumulation with Endothelial Glycocalyx Degradation in People with and without Type 2 Diabetes: A Retrospective Cross-sectional Study. Journal of Atherosclerosis and Thrombosis, 32(12), 1558-1570. https://doi.org/10.5551/jat.65623
Agapitou, C., Sergentanis, T. N., Thymis, J., Pavlidis, G., Lampsas, S., Korakas, E., Kountouri, A., Pliouta, L., Karmiris, E., Lagiou, A., Theodossiadis, P., Lambadiari, V., Ikonomidis, I., & Chatziralli, I. (2024). Retinal Microvascular Changes in Association with Endothelial Glycocalyx Damage and Arterial Stiffness in Patients with Diabetes Mellitus Type 2: A Cross-Sectional Study in a Greek Population. Journal of Personalized Medicine, 14(9), 995. https://doi.org/10.3390/jpm14090995
Andersson, M., Agren, A., Henriksson, P., Wallen, H., & Thorell, A. (2025). Influence of Bariatric Surgery on Endothelial and Glycocalyx Biomarkers in Obesity and Type 2 Diabetes. The Journal of Clinical Endocrinology and Metabolism, 110(10), e3193-e3202. https://doi.org/10.1210/clinem/dgaf092
Schmitz, B., Niehues, H., Lenders, M., Thorwesten, L., Klose, A., Kruger, M., Brand, E., & Brand, S. M. (2019). Effects of high-intensity interval training on microvascular glycocalyx and associated microRNAs. American Journal of Physiology. Heart and Circulatory Physiology, 316(6), H1538-H1551. https://doi.org/10.1152/ajpheart.00751.2018
Gomez Toledo, A., Golden, G. J., Cummings, R. D., Malmstrom, J., & Esko, J. D. (2025). Endothelial Glycocalyx Turnover in Vascular Health and Disease: Rethinking Endothelial Dysfunction. Annual Review of Biochemistry, 94(1), 561-586. https://doi.org/10.1146/annurev-biochem-032620-104745